Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.3K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.3K
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

840
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
840
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Current Trends in Nursing II01:30

Current Trends in Nursing II

1.2K
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
1.2K
Standards of Care II01:19

Standards of Care II

655
Nurses bear specific legal responsibilities under several federal statutes, including:
655
  1. Home
  2. Research Domains
  3. Commerce, Management, Tourism And Services
  4. Accounting, Auditing And Accountability
  5. Auditing And Accountability
  6. Access In All Areas? A Round Up Of Developments In Market Access And Health Technology Assessment: Part 3.
  1. Home
  2. Research Domains
  3. Commerce, Management, Tourism And Services
  4. Accounting, Auditing And Accountability
  5. Auditing And Accountability
  6. Access In All Areas? A Round Up Of Developments In Market Access And Health Technology Assessment: Part 3.

Related Experiment Video

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.7K

Access in all areas? A round up of developments in market access and health technology assessment: part 3.

Alice Beattie1, Catrin Treharne1, Sreeram V Ramagopalan1,2

  • 1Lane Clark & Peacock LLP, London, W1U 1DQ, UK.

Journal of Comparative Effectiveness Research
|February 8, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

This update covers key market access changes, including the UK's VPAG, the Innovative Medicines Fund, France's Direct Access Scheme, and the US ICER value assessment framework.

Keywords:
Canadian Drug AgencyDirect Access SchemeICERInnovative Medicines Fund

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

803

Related Experiment Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.7K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

803

Area of Science:

  • Pharmaceutical market access
  • Health economics
  • Regulatory affairs

Background:

  • Market access strategies are crucial for pharmaceutical product success.
  • Recent policy shifts necessitate an updated understanding of global market access.

Purpose of the Study:

  • To provide a concise overview of significant recent developments in pharmaceutical market access.
  • To highlight key policy changes in the UK, France, and the USA.

Main Methods:

  • Review of recent policy documents and announcements.
  • Analysis of implemented market access schemes and frameworks.
  • Comparative overview of international market access updates.

Main Results:

  • The UK introduced the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG).
VPAG
health technology assessment
health technology management
market access
value assessment framework
  • The UK's Innovative Medicines Fund has begun funding new treatments.
  • France implemented a Direct Access Scheme, and the USA introduced a new ICER value assessment framework.
  • Conclusions:

    • These updates reflect evolving approaches to drug pricing, reimbursement, and value assessment globally.
    • Stakeholders must stay informed about these changes to navigate market access effectively.